Conditions: Schizophrenia
Keywords: Open Label Aripiprazole
Allocation:  | Intervention model: PARALLEL
Enrollment: 85
Healthy volunteers: no

Brief summary:
The purpose of this study is to test the long-term safety and tolerability of oral aripiprazole in adolescent patients with schizophrenia.

Detailed description:

Arms:
arm 1: Flexible dose of oral aripiprazole between 5 mg and 30 mg once daily for 72 months.

Interventions: intervention 1: Aripiprazole
Intervention descriptions: intervention 1: Flexible dose between 5 mg and 30 mg Aripiprazole tablets.

Protocol document: